<rss version="2.0">
<channel>
<title>IBTimes.com RSS Feed - FDA</title>
<description>International Business News - FDA</description>
<link>http://www.ibtimes.com</link>
<copyright>All articles are copyrighted by IBTimes.com</copyright>

<image>
	<title>The International Business Times - Business News, Updated daily</title> 
	<width>400</width> 
	<height>100</height> 
	<link>http://www.ibtimes.com/</link> 
	<url>http://www.ibtimes.com/images/top_logo_ibt2_3.gif</url> 
</image>


  <item>
  <title>Amgen blood-clotting drug decision delayed</title>
  <description>Biotechnology company Amgen Inc. said Wednesday the Food and Drug Administration will not issue a much anticipated decision this week on whether to approve an experimental blood-clotting disorder drug.</description>
    <link>http://www.ibtimes.com/articles/20080723/amgen-blood-clotting-drug-decision-delayed.htm</link> 
  <pubDate>Wed, 23 Jul 2008 10:27:28 EDT</pubDate>
  </item>


  <item>
  <title>NexMed erectile dysfunction drug gets rejected</title>
  <description>NexMed Inc. said Tuesday the Food and Drug Administration rejected its application for an experimental topical treatment for erectile dysfunction. The rejection in the form of a "nonapprovable letter" referred to potential issues in a study performed on mice to test whether the experimental product is carcinogenic. That study was completed in 2002 and the company said it doesn't have to conduct that trial again.</description>
    <link>http://www.ibtimes.com/articles/20080722/nexmed-erectile-dysfunction-drug-gets-rejected.htm</link> 
  <pubDate>Tue, 22 Jul 2008 18:48:14 EDT</pubDate>
  </item>


  <item>
  <title>Bush administration opposes tobacco regulation</title>
  <description>The Bush administration strongly opposes legislation to give federal health authorities the power to regulate tobacco products, a top official said in a letter to Congress obtained by The Associated Press on Tuesday.</description>
    <link>http://www.ibtimes.com/articles/20080722/bush-administration-opposes-tobacco-regulation.htm</link> 
  <pubDate>Tue, 22 Jul 2008 18:54:43 EDT</pubDate>
  </item>


  <item>
  <title>FDA unveils plan to recruit young science staffers</title>
  <description>The Food and Drug Administration has unveiled a plan for recruiting young staffers to replace the hundreds of scientists retiring from the agency. The FDA said Thursday it will launch a two-year fellowship program for physicians, chemists, statisticians and other science professionals interested in food and drug regulation. About 30 to 40 fellows will be accepted for the first program, which begins in October. Some of those accepted are expected to stay on as full-time employees after completing the program, which includes course work and seminars.</description>
    <link>http://www.ibtimes.com/articles/20080718/fda-unveils-plan-to-recruit-young-science-staffers.htm</link> 
  <pubDate>Fri, 18 Jul 2008 08:43:28 EDT</pubDate>
  </item>


  <item>
  <title>Sciele gets FDA request for info on lice treatment</title>
  <description>Specialty pharmaceutical company Sciele Pharma Inc. said Wednesday the Food and Drug Administration asked for more information on its experimental head lice treatment.</description>
    <link>http://www.ibtimes.com/articles/20080716/sciele-gets-fda-request-for-info-on-lice-treatment.htm</link> 
  <pubDate>Wed, 16 Jul 2008 16:21:40 EDT</pubDate>
  </item>


  <item>
  <title>Genentech ends studies on drug combo safety issue</title>
  <description>Biotechnology company Genentech Inc. ended several studies combining its cancer drug Avastin and Pfizer Inc.'s Sutent because several patients developed a type of anemia.</description>
    <link>http://www.ibtimes.com/articles/20080714/genentech-ends-studies-on-drug-combo-safety-issue.htm</link> 
  <pubDate>Mon, 14 Jul 2008 18:35:50 EDT</pubDate>
  </item>


  <item>
  <title>Amgen's FDA Nplate approval statement retracted</title>
  <description>Biotechnology company Amgen Inc. said Business Wire erroneously released a statement from the company Monday, saying the Food and Drug Administration approved its Nplate treatment for a rare type of blood-platelet deficiency condition.</description>
    <link>http://www.ibtimes.com/articles/20080714/amgen-gets-fda-approval-for-platelet-disorder-drug.htm</link> 
  <pubDate>Mon, 14 Jul 2008 12:19:16 EDT</pubDate>
  </item>


  <item>
  <title>Intel gets FDA clearance on in-home medical device</title>
  <description>Chip maker Intel Corp. said Thursday it received market clearance from the U.S. Food and Drug Administration for its in-home personal health system. The Intel Health Guide is a care management tool for health care professionals who manage patients with chronic conditions.</description>
    <link>http://www.ibtimes.com/articles/20080710/intel-gets-fda-clearance-on-in-home-medical-device.htm</link> 
  <pubDate>Thu, 10 Jul 2008 13:17:30 EDT</pubDate>
  </item>


  <item>
  <title>FDA panel to weigh suicide risks of epilepsy drugs</title>
  <description>Pfizer Inc., the world's largest drug maker, is trying to persuade government regulators not to add stern warnings about suicide risks to its best-selling epilepsy drug.</description>
    <link>http://www.ibtimes.com/articles/20080709/fda-panel-to-weigh-suicide-risks-of-epilepsy-drugs.htm</link> 
  <pubDate>Wed, 09 Jul 2008 17:07:03 EDT</pubDate>
  </item>


  <item>
  <title>ViroPharma: FDA committee will have generics focus</title>
  <description>ViroPharma Inc. said Tuesday an upcoming Food and Drug Administration advisory committee meeting will focus on general generic drug issues and not specifically on the company's only marketed treatment, Vancocin.</description>
    <link>http://www.ibtimes.com/articles/20080708/viropharma-fda-committee-will-have-generics-focus.htm</link> 
  <pubDate>Tue, 08 Jul 2008 10:52:14 EDT</pubDate>
  </item>


  <item>
  <title>Biopure plans blood substitute study</title>
  <description>Drug developer Biopure Corp. said Monday it will file a study plan for its experimental blood substitute Hemopure with the Food and Drug Administration, months after the agency was criticized for its lack of action on potential safety risks associated with synthetic blood products.</description>
    <link>http://www.ibtimes.com/articles/20080707/biopure-plans-blood-substitute-study.htm</link> 
  <pubDate>Mon, 07 Jul 2008 10:56:22 EDT</pubDate>
  </item>


  <item>
  <title>Mylan gets FDA OK to market generic antibiotic</title>
  <description>Generic drug maker Mylan Inc. said Thursday it received tentative approval from the Food and Drug Administration to market its 600 milligram linezolid tablets.</description>
    <link>http://www.ibtimes.com/articles/20080703/mylan-gets-fda-ok-to-market-generic-antibiotic.htm</link> 
  <pubDate>Thu, 03 Jul 2008 08:06:53 EDT</pubDate>
  </item>


  <item>
  <title>Abbott gets FDA approval for drug-coated stent</title>
  <description>Drug developer and medical device maker Abbott Laboratories said Wednesday it received Food and Drug Administration approval for its anticipated drug-coated stent, Xience V.</description>
    <link>http://www.ibtimes.com/articles/20080702/abbott-gets-fda-approval-for-drug-coated-stent.htm</link> 
  <pubDate>Wed, 02 Jul 2008 17:36:49 EDT</pubDate>
  </item>


  <item>
  <title>Teva receives FDA approval for generic Risperdal</title>
  <description>Johnson &amp; Johnson&amp;#39;s blockbuster anti-psychotic drug Risperdal will face generic competition, as Teva Pharmaceutical Industries Ltd. on Monday became the first company to receive approval for a generic version.</description>
    <link>http://www.ibtimes.com/articles/20080630/teva-receives-fda-approval-for-generic-risperdal.htm</link> 
  <pubDate>Mon, 30 Jun 2008 17:48:13 EDT</pubDate>
  </item>


  <item>
  <title>GlaxoSmithKline responds to FDA&amp;#39;s Cervarix query</title>
  <description>GlaxoSmithKline PLC said Monday it responded to questions raised by the Food and Drug Administration over the cervical cancer vaccine Cervarix and will provide the agency with more complete late-stage study data in 2009.</description>
    <link>http://www.ibtimes.com/articles/20080630/glaxosmithkline-responds-to-fdas-cervarix-query.htm</link> 
  <pubDate>Mon, 30 Jun 2008 11:56:05 EDT</pubDate>
  </item>


  <item>
  <title>House committee criticizes FDA over bonuses</title>
  <description>A review of bonuses paid to employees at the Food and Drug Administration showed many went to the agency&amp;#39;s highest-paid staff rather than to the inspectors in the field, according to a review by the House Energy and Commerce Committee.</description>
    <link>http://www.ibtimes.com/articles/20080627/house-committee-criticizes-fda-over-bonuses.htm</link> 
  <pubDate>Fri, 27 Jun 2008 08:16:54 EDT</pubDate>
  </item>


  <item>
  <title>House committee criticizes FDA over bonuses</title>
  <description>A review of bonuses paid to employees at the Food and Drug Administration showed many went to the agency&amp;#39;s highest-paid staff rather than to the inspectors in the field, according to a review by the House Energy and Commerce Committee.</description>
    <link>http://www.ibtimes.com/articles/20080626/committee-critical-of-fda-bonuses.htm</link> 
  <pubDate>Thu, 26 Jun 2008 19:26:13 EDT</pubDate>
  </item>


  <item>
  <title>Warner Chilcott gets FDA OK for 150 mg acne drug</title>
  <description>Warner Chilcott Ltd. said Monday the Food and Drug Administration approved a 150 mg strength of Doryx delayed-release tablets as a treatment for severe acne.</description>
    <link>http://www.ibtimes.com/articles/20080623/warner-chilcott-gets-fda-ok-for-150-mg-acne-drug.htm</link> 
  <pubDate>Mon, 23 Jun 2008 08:39:34 EDT</pubDate>
  </item>


  <item>
  <title>Ligand says FDA extends blood-clot drug review</title>
  <description>Drug developer Ligand Pharmaceuticals Inc. said after the bell Friday the Food and Drug Administration will take an additional three months to review its experimental blood-clotting drug Promacta.</description>
    <link>http://www.ibtimes.com/articles/20080620/ligand-says-fda-extends-blood-clot-drug-review.htm</link> 
  <pubDate>Fri, 20 Jun 2008 16:31:25 EDT</pubDate>
  </item>


  <item>
  <title>FDA says deaths with heart imaging drugs continue</title>
  <description>Despite previous warnings to physicians, drugs used to improve medical images of the heart continue to be linked to serious side effects and some deaths, regulators said Friday.</description>
    <link>http://www.ibtimes.com/articles/20080620/fda-says-deaths-with-heart-imaging-drugs-continue.htm</link> 
  <pubDate>Fri, 20 Jun 2008 16:25:23 EDT</pubDate>
  </item>


</channel>
</rss>